Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Weighted Average and Diluted) (2016 - 2025)

Prestige Consumer Healthcare has reported EPS (Weighted Average and Diluted) over the past 16 years, most recently at $0.97 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.97 for Q4 2025, down 20.49% from a year ago — trailing twelve months through Dec 2025 was $3.79 (down 11.24% YoY), and the annual figure for FY2025 was $4.29, up 2.88%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.97 at Prestige Consumer Healthcare, up from $0.86 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for PBH hit a ceiling of $1.22 in Q4 2024 and a floor of -$4.79 in Q1 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $1.02 (2022), compared with a mean of $0.72.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 569.61% in 2023 and later surged 120.46% in 2024.
  • Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) stood at $0.99 in 2021, then grew by 5.05% to $1.04 in 2022, then rose by 1.92% to $1.06 in 2023, then rose by 15.09% to $1.22 in 2024, then fell by 20.49% to $0.97 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.97 (Q4 2025), $0.86 (Q3 2025), and $0.95 (Q2 2025) per Business Quant data.